Firms
Theme

DOCU

DocuSign, Inc. · NASDAQ

News

11 latest

Zacks Investment Research

Docusign Inc. (DOCU) Hit a 52 Week High, Can the Run Continue?

DocuSign (DOCU) has gained 20.3% over the past month and hit a new 52-week high of $80.61, driven by consistent earnings beats and strong growth projections. The company holds a Zacks Rank #2 (Buy) with a VGM Score of B, trading at 17.4X current fiscal year EPS—below the peer average of 20.7X. AppFolio (APPF), another Internet-Software peer, also carries a Zacks Rank #2 rating and shows similar positive momentum.

Zacks Investment Research

DocuSign (DOCU) Outpaces Stock Market Gains: What You Should Know

DocuSign (DOCU) closed at $76.66, up 2.69%, outperforming the S&P 500. The company is forecasted to report EPS of $1.17 (up 15.84% YoY) and revenue of $888.69 million (up 8.59% YoY). Trading at a Forward P/E of 16.2, below its industry average of 20.63, DocuSign holds a Zacks Rank #3 (Hold) rating with recent positive estimate revisions.

Zacks Investment Research

Docusign Inc. (DOCU) Is a Trending Stock: Facts to Know Before Betting on It

DocuSign (DOCU) has outperformed the broader market with a +6.9% return over the past month. The company shows strong earnings growth expectations (+20.1% year-over-year for current fiscal year) and has consistently beaten consensus estimates. However, it received a Zacks Rank #3 (Hold) rating and is trading at a premium valuation (Grade D) compared to peers, suggesting it may perform in line with the broader market in the near term.

Zacks Investment Research

Here's Why You Should Hold DOCU Stock in Your Portfolio Now

Docusign (DOCU) has outperformed the market with a 54.3% gain over six months, driven by strong adoption of its Intelligent Agreement Management (IAM) platform, which contributed 15.1% to ARR in Q2'27. The company reported 16% adjusted operating income growth and 35% free cash flow growth year-over-year.

Zacks Investment Research

Here's Why DocuSign (DOCU) is a Strong Momentum Stock

Zacks Premium offers investment research tools including the Zacks Rank stock-rating system and Style Scores to help investors identify high-performing stocks. The system has historically outperformed the S&P 500 with an average annual return of +23.86% since 1988. DocuSign (DOCU) is highlighted as a stock to watch with a #3 Hold rank and B-rated VGM and Momentum scores, supported by upward earnings revisions.

Zacks Investment Research

DocuSign (DOCU) Increases Despite Market Slip: Here's What You Need to Know

DocuSign stock rose 1.89% to $72.31, outperforming the broader market which declined slightly. The company is expected to report earnings of $1.17 per share (up 15.84% YoY) with projected revenue of $888.77 million (up 8.61% YoY). DocuSign holds a Zacks Rank #3 (Hold) with a Forward P/E of 15.45, trading at a discount to its industry average.

Zacks Investment Research

Here's Why DocuSign (DOCU) is a Strong Growth Stock

Zacks Premium offers Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the best probability of outperformance. The Zacks Rank #1 stocks have averaged +23.86% annual returns since 1988, more than double the S&P 500. DocuSign (DOCU) is highlighted as a stock to watch with a #3 Hold rank and Grade B VGM Score, featuring strong Growth prospects with forecasted 19.5% year-over-year earnings growth.

Zacks Investment Research

DOCU Stock Soars 50.8% in 3 Months: Here's What You Should Know

Docusign (DOCU) has surged 50.8% over the past three months, significantly outperforming its industry and the broader market. The company's success is driven by strong customer momentum with 1.9M+ customers, improved dollar net retention at 103%, and 14% growth in high-value accounts ($300K+ ARR).

Mentions DOCU

Zacks Investment Research

NSP Benefits From HRScale Adoption Amid High Competition

Insperity reported Q2 2026 adjusted earnings of 34 cents per share, up 31% YoY and beating consensus by 3%, with revenues of $1.69B. The company expanded HRScale adoption to nearly 8,000 WSEEs and increased working capital to $180M. However, the company faces headwinds from intense PEO competition, a 1% decline in average paid WSEEs, and elevated debt levels of $419M.

The Motley Fool

CrowdStrike vs. Docusign: Which Technology Stock Is a Better Buy in 2026?

CrowdStrike and Docusign represent two distinct paths in software: CrowdStrike leads in AI-native cybersecurity with 21.7% revenue growth but trades at a 192.6x forward P/E, while Docusign offers profitable operations with 8.2% growth and a 16.7x forward P/E. The author recommends CrowdStrike for stronger long-term growth potential despite higher valuation and volatility from its 2024 outage recovery.

Zacks Investment Research

FactSet's Q4 Earnings Beat Estimates, Revenues Increase 6.3% Y/Y

FactSet Research Systems (FDS) delivered Q4 FY2026 results beating expectations with adjusted EPS of $4.52 (up 11.6% YoY) and revenues of $634.7M (up 6.3% YoY). Organic ASV grew 7% to $2.57B with retention above 95%.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $DOCU · 0 threads

Sign in to post on $DOCU

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev